Studies in non-small cell lung cancer and malignant melanomas showed that HIF-2α expression was related to a poor outcome when HIF-1α was not (Giatromanolaki et al, 2001, 2003). The gene discussed is EPAS1; the disease is non-small cell lung carcinoma.